
September 2013 Oncology


Oral antineoplastics have advantages, but patient adherence is a concern.

Gilotrif (afatinib) is FDA approved for treating certain non-small cell lung cancers.

Why are computerized drug-drug interaction alerts usually ignored?




Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.

The nutritional supplements glucosamine and chondroitin have demonstrated some potential for reducing pain associated with osteoarthritis




Federal rules are very specific.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
Early RSV Vaccine Uptake Among Older Adults Reveals Significant Access Gaps
4
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
5